Why the study?
Recent advances in hypertrophic cardiomyopathy diagnosis and treatment require presentation, with special emphasis on the role of CMR in assessing morphological and functional consequences across different disease stages.
CMR is an essential imaging modality in hypertrophic cardiomyopathy for accurate phenotypic characterization, risk stratification, and detection of structural abnormalities often missed by echocardiography.
The aim of this paper is to present recent advances in hypertrophic cardiomyopathy (HCM) diagnosis and treatment based on a literature review. Special emphasis has been placed on the role of cardiac magnetic resonance imaging (CMR) for the assessment of morphological and functional consequences of different stages of HCM including prognostication. The text is illustrated with the images and data of the HCM patients diagnosed with CMR study in our hospital. CMR is an important tool, particularly relevant in novel risk factors and LV dysfunction groups. The HCM group with overt left ventricular dysfunction is underrecognized, often labelled by clinicians as dilated cardiomyopathy. Advanced diagnostic and management strategies effectively influence the natural history of HCM.
No takes yet. Share an insight, caveat, or question.
Stachera et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: